Health Canada should delay approval of generic OxyContin, health ministers say

HALIFAX – Provincial health ministers are calling on Ottawa to delay the approval of a generic form of OxyContin.

David Wilson, Nova Scotia’s health minister, announced today that provincial and territorial ministers unanimously agreed to ask for the delay until further research is done on the highly addictive drug.

The ministers are meeting in Halifax this week, and their federal counterpart, Leona Aglukkaq, is expected to join them Friday.

Ontario Health Minister Deb Matthews says the pain-relief drug — whether it’s in brand-name or generic form — is too addictive, too easy to tamper with and is causing particularly “devastating” consequences in First Nations communities.

She says there are alternatives to OxyContin that can’t be easily ground up and turned into powders or liquids for illicit use.

The ministers attending the meeting also called on Ottawa to consult the provinces before implementing any possible funding cuts to native and immigrant health programs.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.